Literature DB >> 30361937

Big Data in Head and Neck Cancer.

Carlo Resteghini1, Annalisa Trama2, Elio Borgonovi3, Hykel Hosni4, Giovanni Corrao5, Ester Orlandi6, Giuseppina Calareso7, Loris De Cecco8, Cesare Piazza9,10, Luca Mainardi11, Lisa Licitra12,10.   

Abstract

OPINION STATEMENT: Head and neck cancers can be used as a paradigm for exploring "big data" applications in oncology. Computational strategies derived from big data science hold the promise of shedding new light on the molecular mechanisms driving head and neck cancer pathogenesis, identifying new prognostic and predictive factors, and discovering potential therapeutics against this highly complex disease. Big data strategies integrate robust data input, from radiomics, genomics, and clinical-epidemiological data to deeply describe head and neck cancer characteristics. Thus, big data may advance research generating new knowledge and improve head and neck cancer prognosis supporting clinical decision-making and development of treatment recommendations.

Entities:  

Keywords:  Big data; Decision support system; Evidence based medicine; Forecasting; Genomics; Guidelines; Head and neck cancer; Machine learning; Oncology; Radiomics; Radiotherapy; Support vector machine; Surgery

Mesh:

Year:  2018        PMID: 30361937     DOI: 10.1007/s11864-018-0585-2

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  94 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Quantitative Evaluation of Head and Neck Cancer Treatment-Related Dysphagia in the Development of a Personalized Treatment Deintensification Paradigm.

Authors:  Harry Quon; Xuan Hui; Zhi Cheng; Scott Robertson; Luke Peng; Michael Bowers; Joseph Moore; Amanda Choflet; Alex Thompson; Mariah Muse; Ana Kiess; Brandi Page; Carole Fakhry; Christine Gourin; Jolyne O'Hare; Peter Graham; Michal Szczesniak; Julia Maclean; Ian Cook; Todd McNutt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-08-12       Impact factor: 7.038

3.  Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy.

Authors:  Stefan Schmidt; Annett Linge; Alex Zwanenburg; Stefan Leger; Fabian Lohaus; Constanze Krenn; Steffen Appold; Volker Gudziol; Alexander Nowak; Cläre von Neubeck; Inge Tinhofer; Volker Budach; Ali Sak; Martin Stuschke; Panagiotis Balermpas; Claus Rödel; Hatice Bunea; Anca-Ligia Grosu; Amir Abdollahi; Jürgen Debus; Ute Ganswindt; Claus Belka; Steffi Pigorsch; Stephanie E Combs; David Mönnich; Daniel Zips; Gustavo B Baretton; Frank Buchholz; Michael Baumann; Mechthild Krause; Steffen Löck
Journal:  Clin Cancer Res       Date:  2018-01-03       Impact factor: 12.531

4.  Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study.

Authors:  Annalisa Trama; Laura Botta; Nicola Nicolai; Paolo Giorgi Rossi; Paolo Contiero; Mario Fusco; Michele Lodde; Fabio Pannozzo; Silvano Piffer; Antonella Puppo; Andreas Seeber; Rosario Tumino; Riccardo Valdagni; Gemma Gatta
Journal:  Eur J Cancer       Date:  2016-09-10       Impact factor: 9.162

5.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

6.  Label-free blood serum detection by using surface-enhanced Raman spectroscopy and support vector machine for the preoperative diagnosis of parotid gland tumors.

Authors:  Bing Yan; Bo Li; Zhining Wen; Xianyang Luo; Lili Xue; Longjiang Li
Journal:  BMC Cancer       Date:  2015-10-05       Impact factor: 4.430

7.  Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population.

Authors:  Nigam H Shah; Paea LePendu; Anna Bauer-Mehren; Yohannes T Ghebremariam; Srinivasan V Iyer; Jake Marcus; Kevin T Nead; John P Cooke; Nicholas J Leeper
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

8.  Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry.

Authors:  Sunil Gupta; Truyen Tran; Wei Luo; Dinh Phung; Richard Lee Kennedy; Adam Broad; David Campbell; David Kipp; Madhu Singh; Mustafa Khasraw; Leigh Matheson; David M Ashley; Svetha Venkatesh
Journal:  BMJ Open       Date:  2014-03-17       Impact factor: 2.692

9.  Development of a ten-signature classifier using a support vector machine integrated approach to subdivide the M1 stage into M1a and M1b stages of nasopharyngeal carcinoma with synchronous metastases to better predict patients' survival.

Authors:  Rou Jiang; Rui You; Xiao-Qing Pei; Xiong Zou; Meng-Xia Zhang; Tong-Min Wang; Rui Sun; Dong-Hua Luo; Pei-Yu Huang; Qiu-Yan Chen; Yi-Jun Hua; Lin-Quan Tang; Ling Guo; Hao-Yuan Mo; Chao-Nan Qian; Hai-Qiang Mai; Ming-Huang Hong; Hong-Min Cai; Ming-Yuan Chen
Journal:  Oncotarget       Date:  2016-01-19

10.  Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.

Authors:  Timo M Deist; Frank J W M Dankers; Gilmer Valdes; Robin Wijsman; I-Chow Hsu; Cary Oberije; Tim Lustberg; Johan van Soest; Frank Hoebers; Arthur Jochems; Issam El Naqa; Leonard Wee; Olivier Morin; David R Raleigh; Wouter Bots; Johannes H Kaanders; José Belderbos; Margriet Kwint; Timothy Solberg; René Monshouwer; Johan Bussink; Andre Dekker; Philippe Lambin
Journal:  Med Phys       Date:  2018-06-13       Impact factor: 4.071

View more
  8 in total

Review 1.  Advanced computing solutions for analysis of laryngeal disorders.

Authors:  H Irem Turkmen; M Elif Karsligil
Journal:  Med Biol Eng Comput       Date:  2019-09-06       Impact factor: 2.602

2.  Estimation of laryngeal closure duration during swallowing without invasive X-rays.

Authors:  Shitong Mao; Aliaa Sabry; Yassin Khalifa; James L Coyle; Ervin Sejdic
Journal:  Future Gener Comput Syst       Date:  2020-09-30       Impact factor: 7.187

3.  Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma.

Authors:  Jiqiang He; Xinqi Fang; Mingming Han
Journal:  Front Genet       Date:  2021-05-24       Impact factor: 4.599

4.  Head and neck cutaneous melanoma: 5-year survival analysis in a Serbian university center.

Authors:  Aleksandar Višnjić; Predrag Kovačević; Asen Veličkov; Mariola Stojanović; Stefan Mladenović
Journal:  World J Surg Oncol       Date:  2020-11-29       Impact factor: 2.754

Review 5.  Radiomics and Texture Analysis in Laryngeal Cancer. Looking for New Frontiers in Precision Medicine through Imaging Analysis.

Authors:  Carlos Miguel Chiesa-Estomba; Oier Echaniz; Ekhiñe Larruscain; Jose Angel Gonzalez-Garcia; Jon Alexander Sistiaga-Suarez; Manuel Graña
Journal:  Cancers (Basel)       Date:  2019-09-20       Impact factor: 6.639

Review 6.  Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors.

Authors:  Peter L Stern; Tina Dalianis
Journal:  Viruses       Date:  2021-06-25       Impact factor: 5.048

7.  Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma.

Authors:  Erliang Guo; Xionghui Mao; Xueying Wang; Lunhua Guo; Changming An; Cong Zhang; Kaibin Song; Guohui Wang; Chunbin Duan; Xiwei Zhang; Xianguang Yang; Zhennan Yuan; Ji Sun; Xiaomei Li; Weiwei Yang; Hongxue Meng; Susheng Miao
Journal:  Cell Death Dis       Date:  2021-08-03       Impact factor: 8.469

Review 8.  [Artificial intelligence in otorhinolaryngology].

Authors:  Stefan P Haider; Kariem Sharaf; Philipp Baumeister; Christoph A Reichel
Journal:  HNO       Date:  2021-08-10       Impact factor: 1.284

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.